News

F&G Annuities & Life Reports Strong Financial Performance

F&G Annuities & Life Reports Strong Financial Performance

F&G Annuities & Life Achieves Remarkable Sales and Growth

F&G Annuities & Life, Inc. (NYSE: FG), a prominent provider of insurance solutions, recently shared its impressive financial results for the third quarter ending September 30, 2024. The company has shown remarkable resilience and growth, reinforcing its position in the annuity and life insurance markets.

Financial Overview: A Snapshot

The net loss attributable to common shareholders in this quarter was $10 million or $0.08 per diluted share, a significant decline from the net earnings of $306 million or $2.45 per share reported in the same quarter last year. However, when looking at adjusted net earnings, the picture becomes more positive: F&G reported $156 million in adjusted net earnings, amounting to $1.22 per share, which is an increase from $120 million or $0.96 per share in the previous year's quarter.

Sales Performance

F&G witnessed a record-breaking achievement in gross sales during this period, totaling $3.9 billion. This represents a substantial increase of 39% compared to the third quarter of the previous year, primarily owing to an exceptional performance from its retail channel sales, which reached $3.5 billion—an 84% increase year-over-year. The surge in sales reflects strong consumer demand for retirement products and favorable economic conditions.

Assets Under Management Growth

F&G’s assets under management (AUM), not including flow reinsurance, reached an all-time high of $62.9 billion, growing 20% compared to the previous year. This surge included record managed assets of $52.5 billion, indicating a robust 11% growth from the prior year, driven by new business inflows and net proceeds from debt and equity over the past twelve months.

Strategic Initiatives and Market Response

Chris Blunt, Chief Executive Officer of F&G, expressed confidence about the company’s strategic direction. "Our strong results in the first nine months have positioned us well for the remainder of the year, and we continue to make substantial progress towards our Investor Day goals. We are leveraging our owned distribution strategies and flow reinsurance to maintain strong operating margins, even amidst a changing interest rate environment,” he commented.

Operating Costs and Market Stability

The growth in adjusted net earnings to $179 million in Q3 indicates effective management and operational efficiency adjustments. Additionally, the trailing twelve months adjusted return on assets increased to 126 basis points, showcasing the company’s capability in navigating economic challenges and delivering value to shareholders.

Capital Management and Shareholder Returns

F&G continues to maintain a solid balance sheet, supporting both organic growth initiatives and returning capital to shareholders. In the most recent quarter, the company returned $31 million to shareholders through common and preferred dividends, further solidifying its commitment to enhancing shareholder value.

Looking Ahead

F&G Annuities & Life is poised for a promising future, backed by strong sales figures, robust AUM growth, and a deliberate focus on achieving operational excellence. Moving forward, the company is expected to remain agile in responding to market changes and consumer needs.

Frequently Asked Questions

1. What recent financial results did F&G Annuities & Life report?

F&G reported a net loss of $10 million in Q3 2024, but adjusted net earnings increased to $156 million, reflecting strong operational performance.

2. How did retail sales impact F&G's performance?

Retail channel sales surged to $3.5 billion, marking an 84% year-over-year growth driven by heightened consumer demand for retirement products.

3. What were F&G's total assets under management by the end of Q3 2024?

F&G's assets under management (AUM) reached a record $62.9 billion, a 20% increase from the previous year.

4. What does the future look like for F&G Annuities & Life?

The company is focusing on sustaining growth, maintaining operational efficiency, and returning capital to shareholders, indicating a positive outlook.

5. How does F&G manage its capital and liquidity?

F&G maintains a robust balance sheet, returning $31 million to shareholders through dividends and strategically managing its investments for growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading

Top 5 Most Recently Viewed Articles

FMC Corporation Transitions by Selling Global Specialty Solutions

Updated Category News Views 137

FMC Corporation Transitions by Selling Global Specialty Solutions FMC Corporation (NYSE: FMC), a prominent player in the agricultural sciences sector, has recently completed the sale of its Global Specialty Solutions business. This significant transaction marks a decisive shift in the company's focus to enhance its core operations and streamline its offerings in the...

Continue Reading
CG Oncology's Promising Future: Analysts Highlight Key Developments

Updated Category News Views 88

Analyst Coverage Boosts CG Oncology's Market Prospects Recently, CG Oncology (NASDAQ:CGON) garnered attention when UBS initiated coverage, assigning a Buy rating with an ambitious price target of $60.00. This endorsement underscores the potential of the company’s flagship program, cretostimogene (creto), which targets non-muscle invasive bladder cancer (NMIBC). Positive...

Continue Reading
Current Trends in Cryptocurrency Market: Key Insights

Updated Category News Views 386

Bearish Pressures on Major Cryptocurrencies In recent days, cryptocurrencies have faced significant bearish trends, with only XRP showing some resilience. This decline raises important questions for traders and investors navigating the volatile crypto landscape. Market Overview: Key Cryptocurrency Prices Here are the current prices and performance metrics for the leading...

Continue Reading
Enhanced Cancer Guidelines Include Key Insights on LEMS

Updated Category News Views 146

Updated Guidelines for LEMS and SCLC In a significant advancement, the National Comprehensive Cancer Network (NCCN) has included essential recommendations for Lambert Eaton Myasthenic Syndrome (LEMS) in their Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC). Importance of VGCC Antibody Testing The updated guidelines emphasize the crucial role of VGCC...

Continue Reading
VEON Invests in Ukraine: Commitment to Digital Growth

Updated Category News Views 102

VEON's Commitment to Investing in Ukraine VEON Ltd. (NASDAQ: VEON), a leading global digital operator, has recently made significant news with its promise to enhance Ukraine’s telecommunications infrastructure. In collaboration with its fully-owned subsidiary, Kyivstar, VEON participated in the 2024 Yalta European Strategy (YES) Annual Meeting. At this event, the focus...

Continue Reading